SCHEMBL17037229

SCHEMBL17037229

FC(F)Oc1ccc(-c2nc(CBr)co2)cc1OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 3/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDE4B Q07343 4/20 0.41
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
PTGER1 P34995 1/20 0.36
PPARG P37231 3/20 0.36
PPARA Q07869 3/20 0.36
FFAR1 O14842 2/20 0.35
DRD2 P14416 2/20 0.35
DRD4 P21917 2/20 0.35
DRD3 P35462 2/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE4A P27815 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4280199 0.89 TSHR (0.41) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL19066427 0.89 TSHR (0.41) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL17037230 0.89 TSHR (0.41) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4271714 0.89 TSHR (0.41) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL17243832 0.86 TSHR (0.53) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4278364 0.85 TSHR (0.44) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4284397 0.85 TSHR (0.44) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL28238622 0.85 KDM4E (0.43) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL15521510 0.83 DHODH (0.37) TSHRKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4273722 0.83 ADRA1D (0.39) TSHRKDM4EHSD17B10ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181205-B2 Method for producing oxazole compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-11-10 US disclosed
US-20150239855-A1 Method for Producing Oxazole Compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239855-A1 Method for Producing Oxazole Compound OXA1L, CYB5R3, CBR3 TSHR 1502/4885KDM4E 1373/4885HSD17B10 879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.